Abivax SA (ABVX)
120.16
-2.31
(-1.89%)
USD |
NASDAQ |
Apr 17, 16:00
120.35
+0.19
(+0.16%)
After-Hours: 20:00
Abivax Cash from Investing (Quarterly) : -15.45M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| AstraZeneca PLC | -1.501B |
| Eli Lilly & Co. | -2.802B |
| DBV Technologies SA | -0.7165M |
| Insmed, Inc. | 389.41M |
| Nicox SA | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -27.35M |
| Cash from Financing (Quarterly) | -39.99M |
| Free Cash Flow | -183.79M |
| Free Cash Flow Per Share (Quarterly) | -0.3496 |
| Free Cash Flow to Equity (Quarterly) | 21.79M |
| Free Cash Flow to Firm (Quarterly) | -8.400M |
| Free Cash Flow Yield | -2.20% |